Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$AUPH Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.29 up 81.25% YoY
• Reported revenue of $58.57M down -16.33% YoY
• Aurinia Pharmaceuticals Inc. reiterates its guidance for 2026 total revenue of $315 million to $325 million, up 11% to 15% compared to 2025, and net product sales of $305 million to $315 million.Price since post
Advertisement|Remove ads.